Qu Biologics publishes potentially paradigm-shifting results of their first randomized-placebo controlled trial for the treatment of Crohn’s disease


You May Also Like

Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference

MEDFORD, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs

ALPHARETTA, Ga., July 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...